心力衰竭患者的血容量分析数据阳​​性，达克索上涨156％

交易稀薄的纳米级达克索（DXR + 156.4％）的交易量激增至128倍，以回应其公布的真实世界数据，该数据显示通过对患者进行的血容量分析（BVA）对心力衰竭患者具有重大益处其BVA-100分析仪。结果在佛罗里达州奥兰多市美国心脏病学会科学会议暨博览会上发表。在245名接受BVA指导的个性化护理的心力衰竭患者中，30天全因死亡率为2.0％，比11.1％低82％在匹配的对照人群中（p<0.001), implying a 56% relative reduction in the risk of 30-day readmissions compared to conventionally managed patients.The company says BVA enables clinicians to directly measure a patient"s blood volume, a hallmark of heart failure, with 98% accuracy, adding that the data have significant implications for hospitals since they are penalized by Medicare for 30-day heart failure readmission rates if they are above average.Now read: Invuity prices stock offering at .50; shares down 13%Original articleiv>